What is Delta 8 THC?
Delta 8 THC is a stereoisomer of delta-9-THC, differing only in the location of a double bond. A stereoisomer is a molecule which, although otherwise identical, differs only slightly in the arrangement of their atoms. This different arrangement of atoms is what makes delta-8-THC function in a slightly different way then other tetrahydrocannabinols.
Delta 8 does not induce the deleterious side effects of dizziness, drowsiness, and mood changes often found when using delta 9 THC. Delta-8-THC is reported to offer a much more relaxing high than delta-9 thc, and may have anti-anxiety, antiemetic and pain-killing properties. Research into delta 8 THC has all been unanimous on the fact that this tetrahydrocannabinol is able to compete with delta 9 THC in its medicinal values.
Delta 8 THC Research
Although research has historically centered around delta 9 THC, delta 8 THC research began as early as 1974 when scientists discovered that this cannabinoid destroyed cancer cells in mice. Cannabis' legal status has now allowed the medical community to more carefully study this novel cannabinoid and its potential for cancer treatment.
Delta 8 thc has been linked with complete reductions in nausea, reduced pain, increased appetite in patients undergoing chemotherapy or patients with eating disorders. It also reduced intraocular pressure in glaucoma patients and promotes positive changes in neurotransmitter activation in key regions of the brain, including the hippocampus and hypothalamus.
One investigation that has truly highlighted delta 8 thc’s medical efficacy is its work as an antiemetic in children. Researchers found that when given a dose of purified delta 8 THC two hours before chemotherapy began, vomiting, which is often the most severe side effect of anticancer therapy, was completely prevented.
In addition to stellar performances in clinical settings, delta 8 THC does not undergo oxidation to cannabinol (CBN), making it much more stable and is less costly to produce than delta 9.